Apr. 9 at 10:12 AM
WATCHLIST APR 09 2025.
$RXRX Recursion Announces First Patient Dosed In Phase 1 Clinical Study Of REC-3565 For Relapsed Or Refractory B-cell Lymphomas
$AIRJ AirJoule Technologies Partners With Arizona State University To Supply High-Capacity AirJoule A250TM System For Water Harvesting Research, Demonstrating Over 4x Efficiency Compared To Traditional Moisture Removal Systems
$CVRX Lake Street Maintains Buy on CVRx, Lowers Price Target to
$14
$NTHI NeOnc Technologies shares are trading higher after the company announced near full enrollment for its Phase 1 clinical trial of NEO212 for brain cancer
$ANNX Annexon Says Tanruprubart Met The Primary Endpoint; Demonstrates Rapid, Durable Recovery and Superior Efficacy In First Placebo-Controlled Phase 3 GBS Trial, Showing Significant Improvement In Motor Function, Mobility, and Disability Measures Over Placebo With No New Safety Signals